Quick Links
Resources
About myMPNteam
Powered By
Below is a listing of treatments and therapies for MPN. Click on one to read more information or connect with others currently using it.
Overview
Besremi is approved by the U.S. Food and Drug Administration (FDA) specifically for the treatment of polycythemia vera (PV), a type of myeloproliferative neoplasm characterized by the overproduction of red blood…
Overview
Bosulif is approved by the U.S. Food and Drug Administration (FDA) for treating Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML), a type of myeloproliferative neoplasm (MPN), in adults and…
Overview
Gleevec is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults and children with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) — a type of … read more
Overview
Iclusig is approved by the U.S. Food and Drug Administration (FDA) to treat certain types of chronic myeloid leukemia (CML), a type of myeloproliferative neoplasm (MPN), in adults. Doctors prescribe Iclusig to…
Overview
Imkeldi is approved by the U.S. Food and Drug Administration (FDA) to treat certain types of myeloproliferative neoplasms (MPNs), including Philadelphia chromosome-positive (Ph-positive) chronic myeloid leukemia…
Overview
Inrebic is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with intermediate or high-risk primary or secondary myelofibrosis, a cancer of the bone marrow. Inrebic is… read more
Overview
Jakafi is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera… read more
Sign up for free!
Continue with Facebook
Sign up with your email
